RNA
Atrium Therapeutics, Inc.
8.00$
+1.7%
vs. previous close
Closing price · As of: Oct 5, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 96.9% | 97.3% | 98.2% | 98.6% | 98.8% | 98.6% | 98.3% | 91.4% | 97.7% | 98.0% | 97.7% | 98.1% | |
| 14.9% | 29.4% | 49.5% | 42.7% | 22.6% | 14.1% | 17.4% | 17.8% | 97.3% | 97.0% | 91.6% | 25.9% | |
| 94.7% | 94.7% | 96.3% | 96.4% | 96.8% | 96.0% | 94.6% | 86.4% | 97.3% | 97.0% | 91.6% | 94.2% | |
| 0.2% | 1.4% | 1.0% | 1.2% | 1.2% | 1.8% | 2.5% | 0.6% | 5.4% | 4.5% | 5.1% | – | |
| -0.2% | – | – | -1.2% | – | – | – | – | – | – | – | – | |
| 9.7% | 20.3% | 12.7% | 9.4% | 8.4% | 8.9% | 8.9% | 12.9% | 23.3% | 25.5% | 19.9% | 23.5% | |
| 8.5% | 12.8% | 7.9% | 6.2% | 5.6% | 6.3% | 5.8% | 9.9% | 11.4% | 15.0% | 7.5% | 11.2% | |
| 0.6% | 0.6% | 0.4% | 0.3% | 0.2% | 0.2% | 0.3% | 0.3% | 1.4% | 1.3% | 0.9% | 0.6% | |
| 1.0% | 1.4% | 0.2% | 0.7% | 0.5% | 0.5% | 0.5% | 0.3% | 0.2% | 1.6% | 0.3% | 1.3% | |
| 90.3% | 79.7% | 87.3% | 90.6% | 91.6% | 91.1% | 91.1% | 87.1% | 76.7% | 74.5% | 80.1% | 76.5% | |
| -89.0% | -90.8% | -67.2% | -52.7% | -48.2% | -57.1% | -69.1% | -85.2% | -483.0% | -566.8% | 4.1% | -2.9% | |
| 12.9% | 12.1% | 9.2% | 7.9% | 7.5% | 8.2% | 8.9% | 9.5% | 49.7% | 6.1% | 5.9% | 6.1% |
Data as of: October 5, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.